Global Cord Blood (NYSE:CO) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO) in a research note released on Wednesday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Stock Performance

CO stock opened at $1.25 on Wednesday. The company has a fifty day moving average price of $1.58 and a 200-day moving average price of $1.40. The company has a market capitalization of $151.94 million, a P/E ratio of 1.95 and a beta of 0.16. Global Cord Blood has a 52-week low of $2.03 and a 52-week high of $5.50.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.